Tag: FDA bioequivalence guidelines
Narrow Therapeutic Index Drugs: Why Stricter Bioequivalence Rules Matter
Explore why Narrow Therapeutic Index (NTI) drugs face stricter bioequivalence rules. Learn how FDA, EMA, and Health Canada ensure generic safety for critical meds like warfarin and levothyroxine.
